Research Article| Volume 42, ISSUE 12, P1835-1838, August 2006

Download started.


Past chlamydial infection is not associated with primary fallopian tube carcinoma


      We conducted a retrospective seroepidemiological study to evaluate the relationship between past chlamydial infection and primary fallopian tube carcinoma (PFTC). Postoperative serum samples were drawn from 79 consecutive patients treated for PFTC in 1985–2000. For each case two controls were selected. Serum samples were analysed for IgG antibodies to different C. trachomatis serotype pools and to C. pneumoniae. Seropositivity in general or serum antibody levels to different C. trachomatis serovars or C. pneumoniae did not differ between PFTC patients and controls. The lack of association between anti-chlamydial antibodies and PFTC suggests that past chlamydial infection does not play a role in the etiopathogenesis of PFTC. However, because chlamydial infection is common at young age and PFTC develops decades later, we cannot definitively exclude the possibility that C.trachomatis contributes to the development of PFTC.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nordin A.J.
        Primary carcinoma of fallopian tube: a 30-year literature review.
        Obstet Gynecol Surv. 1994; 49: 349-361
        • Riska A.
        • Leminen A.
        • Pukkala E.
        Sociodemographic determinants of incidence of primary fallopian tube carcinoma.
        Int J Cancer. 2003; 104: 643-645
        • Wilson J.S.
        • Honey E.
        • Templeton A.
        • et al.
        • for the EU Biome Concerted Action Group
        A systematic review of the prevalence of Chlamydia trachomatis among European women.
        Hum Reprod Update. 2002; 8: 385-394
        • Paavonen J.
        • Molander P.
        Pelvic inflammatory disease.
        in: Shaw A. Gynecology. Churchill Livingstone, Edinburgh2003: 891-900
        • Paavonen J.
        • Eggert-Kruse W.
        Chlamydia trachomatis: impact on human reproduction.
        Hum Reprod Update. 1999; 5: 433-447
        • Hogan R.J.
        • Mathews S.A.
        • Mukhopadhyay S.
        • Summersgrill J.T.
        • Timms P.
        Chlamydial persistence: beyond the biphasic paradigm.
        Infect Immun. 2004; 72: 1843-1855
        • Rosin M.P.
        • Anwar W.A.
        • Ward J.A.
        Inflammation, chromosomal instability and cancer: the schistosomiasis model.
        Cancer Res. 1994; 54: 1929-1933
        • Koskela P.
        • Anttila T.
        • Bjorge T.
        • et al.
        Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
        Int J Cancer. 2000; 85: 35-39
        • Anttila T.
        • Saikku P.
        • Koskela P.
        • et al.
        Serotypes of Chlamydia trachomatis and risk for cervical squamous cell carcinoma.
        JAMA. 2001; 285: 47-51
        • Shu W.O.
        • Brinton L.A.
        • Gao Y.T.
        • Yuan J.M.
        Population-based case-control-study of ovarian cancer in Shanghai.
        Cancer Res. 1989; 49: 3670-3674
        • Risch H.A.
        • Howe G.R.
        Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
        Cancer Epidemiol Biomarkers Prev. 1995; 4: 447-451
        • Paavonen J.
        Chlamydia and cancer.
        Gynecol Forum. 1998; 3: 17-20
        • Wang S.-P.
        • Grayston J.T.
        Immunologic relationship between genital TRIC, lymphogranuloma venerum, and related organisms in a new microtiter indirect-immunofluorescent test.
        Am J Ophthalmol. 1970; 70: 367-374
        • Anttila T.
        • Lehtinen T.
        • Leinonen M.
        • et al.
        Serological evidence of an association between chlamydial infections and malignant lymphomas.
        Br J Haematol. 1998; 103: 150-156
        • Hosmer D.W.
        • Lemeshow S.
        Applied logistic regression.
        2nd ed. John Wiley & Sons, New York2000
        • Gungor T.
        • Keskin H.L.
        • Zergeroglu S.
        • et al.
        Tuberculous salpingitis in two of five primary fallopian tube carcinomas.
        J Obstet Gynaecol. 2003; 23: 193-195
        • Paavonen J.
        Pelvic inflammatory disease. From diagnosis to prevention.
        Dermatol Clin. 1998; 16: 747-756
        • Kinnunen A.
        • Surcel H.-M.
        • Halttunen M.
        • et al.
        Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women.
        Clin Exp Imm. 2003; 131: 299-303
        • Ness R.
        • Grisso J.
        • Cottreau C.
        • et al.
        Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.
        Epidemiology. 2000; 11: 111-117
        • Fan T.
        • Lu H.
        • Hu H.
        • et al.
        Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation.
        J Exp Med. 1998; 187: 487-496
        • Parazzini F.
        • LaVecchia C.
        • Negri E.
        • Moroni S.
        • dal Pino D.
        • Fedele L.
        Pelvic inflammatory disease and risk of ovarian cancer.
        Cancer Epidemiol Biomarkers Prev. 1996; 5: 667-669
        • Bosch F.X.
        • Cardis E.
        Cancer incidence correlations: genital, urinary and some tobacco-related cancers.
        Int J Cancer. 1990; 46: 178-184
        • Hankinson S.E.
        • Hunter D.J.
        • Colditz G.A.
        • et al.
        Tubal ligation, hysterectomy, and risk of ovarian cancer.
        JAMA. 1993; 270: 2813-2818
        • Puolakkainen M.
        • Vesterinen E.
        • Purola E.
        • Saikku P.
        • Paavonen J.
        Persistence of chlamydial antibodies after pelvic inflammatory disease.
        J Clin Microbiol. 1986; 23: 924-928